Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Helsinki L. Teppo"'
Autor:
Marshfield D. Reding, Detroit R. Demers, Helsinki A. Auvinen, Rotterdam R. Kranse, Alabama A. Oberman, Rotterdam P. Beensterboer, Florence R. Bonardi, Cardiff A. Turkes, Rotterdam F.H. Schröder, Bethesda J. Gohagan, Bethesda N. Simpson, Rotterdam M.A. Dijk, Pittsburgh J.L. Weissfeld, Bethesda P.C. Prorok, Rotterdam J.W.B.W. Rietbergen, Goteborg J. Hugosson, Helsinki L. Teppo, Goteburg G. Aus, Washington E.P. Gellman, Toronto A.B. Miller, Tampere M. Hakama, Quebec B. Candas, Minneapolis J. Mandel, Florence S. Ciatto, Brussels B. Stadaert, Madrid A.B. Sanchez, Madrid A. Paez, St. Louis G.L. Andriole, Lisbon E.C. da Silva, Rotterdam W.I. Kirkels, Antwerp V. Nelen, Rotterdam H.J. de Koning, Lisbon F. Figueiredo, Salt Lake City S. Buys, Rotterdam B.G. Blijenberg, Leeds P.H. Smith, Lund H. Lilja, Antwerp L. Denis, Denver E.D. Crawford, Helsinki U.H. Stenman, Helsinki L. Määttänen, Rotterdam Th.H. van der Kwast, Lisbon H. Monteiro, Antwerp D.B. Rose
Publikováno v:
European Journal of Cancer. 35:262-271
Screening for prostate cancer has been advocated by a number of organisations largely because there is good evidence that administration of the test for prostate specific antigen (PSA) results in the detection of cancers at an early stage. However, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae71f5dd6a71eb361d184e57a8ddf452
https://doi.org/10.1016/s0959-8049(98)00379-7
https://doi.org/10.1016/s0959-8049(98)00379-7
